{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:25:48Z","timestamp":1786983948242,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Jesse and Julie Rasch Foundation"},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.abb.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T11:32:51Z","timestamp":1524051171000},"page":"12-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice"],"prefix":"10.1016","volume":"648","author":[{"given":"Jacob","family":"Guorgui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mattheolabakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-7165","authenticated-orcid":false,"given":"Gerardo G.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.abb.2018.04.012_bib1","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1182\/blood-2004-12-4750","article-title":"From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential","volume":"105","author":"Re","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.abb.2018.04.012_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.bcp.2007.08.016","article-title":"Curcumin as \u201cCurecumin\u201d: from kitchen to clinic","volume":"75","author":"Goel","year":"2008","journal-title":"Biochem. Pharmacol."},{"issue":"9","key":"10.1016\/j.abb.2018.04.012_bib3","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mnfr.200700354","article-title":"Multi-targeted therapy by curcumin: how spicy is it?","volume":"52","author":"Goel","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.abb.2018.04.012_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ijc.23477","article-title":"Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells","volume":"123","author":"Mackenzie","year":"2008","journal-title":"Int. J. Canc."},{"issue":"12","key":"10.1016\/j.abb.2018.04.012_bib5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"issue":"2\u20133","key":"10.1016\/j.abb.2018.04.012_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0169-409X(01)00105-3","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"47","author":"Mehnert","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.abb.2018.04.012_bib7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/phrs.2000.0695","article-title":"Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats","volume":"42","author":"Fundaro","year":"2000","journal-title":"Pharmacol. Res. : the official journal of the Italian Pharmacological Society"},{"issue":"4","key":"10.1016\/j.abb.2018.04.012_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/10611860290031868","article-title":"Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues","volume":"10","author":"Zara","year":"2002","journal-title":"J. Drug Target."},{"issue":"5","key":"10.1016\/j.abb.2018.04.012_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/02652040701799598","article-title":"Development and characterization of 5-FU bearing ferritin appended solid lipid nanoparticles for tumour targeting","volume":"25","author":"Jain","year":"2008","journal-title":"J. Microencapsul."},{"issue":"2","key":"10.1016\/j.abb.2018.04.012_bib10","doi-asserted-by":"crossref","first-page":"E254","DOI":"10.1007\/BF02854895","article-title":"Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice","volume":"8","author":"Reddy","year":"2006","journal-title":"AAPS J."},{"issue":"11","key":"10.1016\/j.abb.2018.04.012_bib11","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1007\/s11095-012-0801-x","article-title":"Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles","volume":"29","author":"Zhu","year":"2012","journal-title":"Pharmaceut. Res."},{"issue":"8","key":"10.1016\/j.abb.2018.04.012_bib12","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1016\/j.msec.2013.07.047","article-title":"The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo","volume":"33","author":"Wang","year":"2013","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"7","key":"10.1016\/j.abb.2018.04.012_bib13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ejp.620","article-title":"Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats","volume":"19","author":"Arora","year":"2015","journal-title":"Eur. J. Pain"},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib14","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3390\/pharmaceutics9030024","article-title":"Multiple functions of d-alpha-tocopherol polyethylene glycol 1000 succinate (TPGS) as curcumin nanoparticle stabilizer: in vivo kinetic profile and anti-ulcerative colitis analysis in animal model","volume":"9","author":"Rachmawati","year":"2017","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib15","doi-asserted-by":"crossref","first-page":"E24","DOI":"10.3390\/pharmaceutics8030024","article-title":"TPGS-stabilized curcumin nanoparticles exhibit superior effect on carrageenan-induced inflammation in wistar rat","volume":"8","author":"Rachmawati","year":"2016","journal-title":"Pharmaceutics"},{"issue":"4\u20135","key":"10.1016\/j.abb.2018.04.012_bib16","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2005.04.003","article-title":"Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo","volume":"25","author":"Varma","year":"2005","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s12253-011-9494-4","article-title":"ABVD as the treatment option in advanced Hodgkin's lymphoma patients older than 45 years","volume":"18","author":"Andjelic","year":"2012","journal-title":"Pathol. Oncol. Res."},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1100340","article-title":"Italiano di Terapie Innovative nei, L. Intergruppo Italiano, ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned","volume":"365","author":"Viviani","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.abb.2018.04.012_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1158\/1940-6207.CAPR-08-0042","article-title":"Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial","volume":"1","author":"Meyskens","year":"2008","journal-title":"Canc. Prev. Res."},{"issue":"1","key":"10.1016\/j.abb.2018.04.012_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1208\/s12248-012-9432-8","article-title":"Therapeutic roles of curcumin: lessons learned from clinical trials","volume":"15","author":"Gupta","year":"2013","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.2011.05648.x","article-title":"Discovery of curcumin, a component of golden spice, and its miraculous biological activities","volume":"39","author":"Gupta","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"7","key":"10.1016\/j.abb.2018.04.012_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10717544.2012.721143","article-title":"Native and beta-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer","volume":"19","author":"Rahman","year":"2012","journal-title":"Drug delivery"},{"issue":"10","key":"10.1016\/j.abb.2018.04.012_bib23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harbor perspectives in biology"},{"issue":"1","key":"10.1016\/j.abb.2018.04.012_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2141.2002.03575.x","article-title":"Interleukin 6 expression by Hodgkin\/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease","volume":"118","author":"Reynolds","year":"2002","journal-title":"Br. J. Haematol."},{"issue":"11","key":"10.1016\/j.abb.2018.04.012_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.185","article-title":"Reed-Sternberg cells in Hodgkin's lymphoma present features of cellular senescence","volume":"7","author":"Gopas","year":"2016","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.abb.2018.04.012_bib26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography\/computed tomography scan after two ABVD cycles: long-term results of the GITIL\/FIL HD 0607 trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.abb.2018.04.012_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1376745","article-title":"Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD x two cycles followed by FDG-PET\/CT restaging and 20 Gy of involved-site radiotherapy","author":"Kamran","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.abb.2018.04.012_bib28","article-title":"Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma","volume":"5","author":"Skoetz","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.abb.2018.04.012_bib29","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/annonc\/mdx005","article-title":"ABVD chemotherapy with reduced radiation therapy rates in children, adolescents and young adults with all stages of Hodgkin lymphoma","volume":"28","author":"Marr","year":"2017","journal-title":"Ann. Oncol. : official journal of the European Society for Medical Oncology \/ ESMO"},{"issue":"4","key":"10.1016\/j.abb.2018.04.012_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12185-016-2080-5","article-title":"Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis","volume":"104","author":"Jiang","year":"2016","journal-title":"Int. J. Hematol."},{"issue":"3","key":"10.1016\/j.abb.2018.04.012_bib31","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118301929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986118301929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T00:20:37Z","timestamp":1571185237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986118301929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":31,"alternative-id":["S0003986118301929"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2018.04.012","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}